3B Blackbio Diagnostics Ltd. (3BBLACKBIO)
BSE
Closed
Aug 25, 2026
Day's Range
1,230.0052 wk Range
1,083.50Overview - 3BBLACKBIO - 3B Blackbio Diagnostics Ltd.
Key Statistics
Valuation
Enterprise Value
10.57B
P/E (Trailing)
‪20.09‬
Price / Sales (TTM)
‪7.07‬
Price / Book
‪3.24‬
EV / EBITDA
‪19.18‬
Profitability
Gross Margin
‪78.67%‬
Profit Margin
‪36.25%‬
Operating Margin
‪21.43%‬
Return on Assets
‪15.49%‬
Return on Equity
‪17.66%‬
Ownership
Shares Outstanding
8.58M
Float
2.93M
Held by Insiders
‪66.15%‬
Held by Institutions
‪1.94%‬
Price stats
Beta
‪0.41‬
50-Day Avg
‪1,214.27‬
200-Day Avg
‪1,320.69‬
Dividends
Payout Ratio
‪6.03%‬
Market Cap - 3BBLACKBIO - 3B Blackbio Diagnostics Ltd.
Peers - 3BBLACKBIO - 3B Blackbio Diagnostics Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on BSE.
Profile Summary - 3BBLACKBIO - 3B Blackbio Diagnostics Ltd.
About
3B Blackbio Diagnostics Ltd. is a biotechnology and diagnostics company focused on providing innovative solutions in the field of molecular diagnostics. Its core activity revolves around the development and commercialization of diagnostic test kits that are essential for identifying various infectious diseases,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
